Teodoro Padilla, Executive Director at the Pharmaceutical and Healthcare Association of the Philippines, and Reiner Gloor, Advisor and Honorary Member, discuss the current objectives and goals of the association, how they are adapting to recent changes in the country’s healthcare landscape, and the impact of the rise of generics.
To begin, could you please describe for our readers some of the recent developments in the country that are pertinent to the Pharmaceutical and Healthcare Association of the Philippines (PHAP) as well as some of your recent activities?
The upper classes know the type of services that they are entitled to, and the lower classes do not. So this is really a matter of educating people.
